MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,000 | -75.3% | 63,485 | +10.2% | 0.00% | -100.0% |
| Q4 2021 | $154,000 | -6.1% | 57,612 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $164,000 | -5.2% | 59,336 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $173,000 | -21.0% | 60,746 | -5.0% | 0.00% | 0.0% |
| Q1 2021 | $219,000 | +30.4% | 63,921 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $168,000 | -13.0% | 63,752 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $193,000 | -26.1% | 61,779 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $261,000 | +169.1% | 63,183 | +5.3% | 0.00% | 0.0% |
| Q1 2020 | $97,000 | -11.0% | 59,983 | +36.0% | 0.00% | – |
| Q4 2019 | $109,000 | +51.4% | 44,089 | +2.5% | 0.00% | – |
| Q3 2019 | $72,000 | -33.9% | 43,032 | -0.7% | 0.00% | – |
| Q2 2019 | $109,000 | -99.9% | 43,332 | +428.2% | 0.00% | – |
| Q1 2014 | $91,299,000 | +42.4% | 8,203 | +2.5% | 0.00% | – |
| Q4 2013 | $64,128,000 | -12.2% | 8,006 | +24.3% | 0.00% | – |
| Q3 2013 | $73,030,000 | – | 6,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 3,039,038 | $9,482,000 | 7.48% |
| Asymmetry Capital Management, L.P. | 787,359 | $2,457,000 | 1.58% |
| First Light Asset Management, LLC | 3,763,804 | $11,743,000 | 1.20% |
| NEA Management Company, LLC | 8,533,072 | $26,623,000 | 1.13% |
| Opaleye Management Inc. | 1,556,000 | $4,855,000 | 0.95% |
| BVF INC/IL | 4,080,162 | $12,730,000 | 0.69% |
| DAFNA Capital Management LLC | 666,000 | $2,078,000 | 0.68% |
| CAXTON CORP | 175,560 | $548,000 | 0.52% |
| Alambic Investment Management, L.P. | 12,500 | $39,000 | 0.43% |
| Boxer Capital, LLC | 2,913,091 | $9,089,000 | 0.31% |